Targeting Glioblastoma with CAR T Cells
- PMID: 28108463
- DOI: 10.1158/2159-8290.CD-NB2017-007
Targeting Glioblastoma with CAR T Cells
Abstract
CAR T cells targeting IL13Rα2 proved effective against recurrent multifocal leptomeningeal glioblastoma, according to a case report. Direct delivery of the therapy into the cerebrospinal fluid was well tolerated, completely eliminating the patient's brain and spinal tumors for 7.5 months, during which the patient resumed his normal activities.
©2017 American Association for Cancer Research.
Comment on
-
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497. N Engl J Med. 2016. PMID: 28029927 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical